Breaking News Instant updates and real-time market news.

2018-10-12 07:15:24 LXP Lexington Realty $7.80 -0.23 (-2.86%) 07:15 10/12/18 10/12 07:15 10/12/18 07:15	Lexington Realty upgraded to Buy from Hold at Jefferies Jefferies analyst Jonathan Petersen upgraded Lexington Realty Trust to Buy and raised his price target for the shares to $10 from $9. While the pending dividend cut has driven yield investors "to the exits," Lexington's shift toward industrial properties and away from office can drive greater than 50% multiple expansion, Petersen tells investors in a research note. He believes this can offset the 30% earnings dilution from the shift.
LXP Lexington Realty $7.80 -0.23 (-2.86%) 05/08/18 STFL 05/08/18 DOWNGRADE STFL Sell Lexington Realty downgraded to Sell from Hold at Stifel 05/09/18 05/09/18 DOWNGRADE Target $7 Sell Lexington Realty downgraded to Sell on view of 'painful transition' at Stifel As previously reported, Stifel analyst John Guinee downgraded Lexington Realty to Sell from Hold as he sees little chance of FFO growth, does not like the real estate valuation metrics and projects a "painful transition" will be required. Guinee also cites a lack of confidence in the current dividend. He lowered his price target on Lexington Realty to $7.00 from $8.50. 08/08/18 08/08/18 NO CHANGE Lexington Realty backs FY18 adjusted FFO view 95c-98c, consensus 97c 09/27/18 WELS 09/27/18 UPGRADE Target $9 WELS Outperform Lexington Realty upgraded to Outperform from Market Perform at Wells Fargo Wells Fargo analyst Todd Stender upgraded Lexington Realty Trust to Outperform and raised his price target for the shares to $9 from $8.50. The analyst likes company's recent announcement to sell a meaningful single-tenant suburban office building portfolio into a joint venture with Davidson Kempner Capital Management. He views Lexington's strategic shift favorably though does acknowledge the earnings dilution and potential dividend cut that may result. Now the company can focus on building out a more competitive footprint within one of the most sought-after property types within the overall REIT group, Industrial/Distribution, which should lead to multiple expansion, Stender tells investors in a research note.

2018-10-12 07:15:24

LXP

Lexington Realty

$7.80: -0.23 (-2.86%)

07:15

10/12/18

10/12

07:15

10/12/18

07:15

Lexington Realty upgraded to Buy from Hold at Jefferies

Jefferies analyst Jonathan Petersen upgraded Lexington Realty Trust to Buy and raised his price target for the shares to $10 from $9. While the pending dividend cut has driven yield investors "to the exits," Lexington's shift toward industrial properties and away from office can drive greater than 50% multiple expansion, Petersen tells investors in a research note. He believes this can offset the 30% earnings dilution from the shift.

LXP Lexington Realty

$7.80: -0.23 (-2.86%)

05/08/18: STFL

05/09/18

08/08/18

09/27/18: WELS

TODAY'S FREE FLY STORIES

BIIB Biogen $319.85 -10.4 (-3.15%) 14:57 10/20/18 10/20 14:57 10/20/18 14:57 Conference/Events	Biogen to host conference call » Chief Medical Officer… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Oct 23 Oct 25 Oct
SELB Selecta Biosciences $13.80 -1.34 (-8.85%) 14:13 10/20/18 10/20 14:13 10/20/18 14:13 Conference/Events	Selecta Biosciences to host conference call » Management discusses the… Management discusses the Phase 2 data for SEL-212 presented at the 2018 ACR Annual Meeting on a conference call to be held on October 23 at 8 am. Webcast Link 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	23 Oct
TROV Trovagene $1.12 -0.03 (-2.61%) 14:11 10/20/18 10/20 14:11 10/20/18 14:11 Conference/Events	Trovagene to host conference call » Management provides an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SLS Sellas Life Sciences $1.56 -0.24 (-13.33%) 13:54 10/20/18 10/20 13:54 10/20/18 13:54 Conference/Events	Sellas Life Sciences to host conference call » Management provides a… Management provides a review of the presentation on the Phase 2b results of NeuVax + Herceptin at 2018 ESMO Annual Meeting on a conference call to be held on October 22 at 8 am. Webcast Link 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Oct 07 Nov
NVS Novartis $87.19 0.95 (1.10%) 13:50 10/20/18 10/20 13:50 10/20/18 13:50 Conference/Events	Novartis to host conference call » Management discusses the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Oct 07 Nov

UA Under Armour $16.79 -0.365 (-2.13%) , UAA Under Armour $18.20 -0.42 (-2.26%) 12:43 10/20/18 10/20 12:43 10/20/18 12:43 Periodicals	Under Armour stock could triple, Barron's says » Under Armour has had a… Under Armour has had a bumpy ride the last couple of years, but has recovered some of the losses amid significant management changes, Al Root writes in this week's edition of Barron's. It could be a good time to take a fresh look at the stock as a contrarian bet, before margins improve and Wall Street warms to the turnaround plan, Root says. Reference Link UA Under Armour $16.79 -0.365 (-2.13%) UAA Under Armour $18.20 -0.42 (-2.26%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	30 Oct 30 Oct 27 Nov 03 Mar
STZ Constellation Brands $222.98 -2.36 (-1.05%) , CGC Canopy Growth $46.87 -1.99 (-4.07%) 12:37 10/20/18 10/20 12:37 10/20/18 12:37 Periodicals	Constellation Brands changing CEOs, not marijuana strategy, Barron's says » Constellation Brands… STZ Constellation Brands $222.98 -2.36 (-1.05%) CGC Canopy Growth $46.87 -1.99 (-4.07%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	28 Oct 14 Nov
CFG Citizens Financial $36.36 1.44 (4.12%) , AAPL Apple $219.28 3.3 (1.53%) 12:33 10/20/18 10/20 12:33 10/20/18 12:33 Periodicals	Citizens Financial stock worth buying, Barron's says » Citizens Financial (CFG)… Citizens Financial (CFG) has one of the hottest lending niches in the world and it is the exclusive financing partner for iPhones bought directly from Apple (AAPL), Lawrence Strauss writes in this week's edition of Barron's. Initiatives like that are helping the bank post steady growth in its total book of loans at a time when many rivals are struggling for any growth at all, the report notes. But the market has not given Citizens Financial any credit for strong loan growth and improving returns, Strauss contends. Reference Link CFG Citizens Financial $36.36 1.44 (4.12%) AAPL Apple $219.28 3.3 (1.53%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
FB Facebook $153.95 -1 (-0.65%) , AAPL Apple $219.28 3.3 (1.53%) … 12:26 10/20/18 10/20 12:26 10/20/18 12:26 Periodicals	Netflix emerged as winner in new way to rank big tech stocks risk, Barron's says » A year ago,… FB Facebook $153.95 -1 (-0.65%) AAPL Apple $219.28 3.3 (1.53%) AMZN Amazon.com $1,763.91 -7.54 (-0.43%) NFLX Netflix $332.69 -14.02 (-4.04%) GOOG Alphabet $1,096.41 8.51 (0.78%) GOOGL Alphabet Class A $1,104.66 7.43 (0.68%) DIS Disney $118.81 2.55 (2.19%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Oct 25 Oct 25 Oct 25 Oct 28 Oct 30 Oct 07 Nov 08 Nov 13 Nov 03 Mar
BABA Alibaba $142.90 1.1 (0.78%) , TCEHY Tencent $0.00 (0.00%) … 12:17 10/20/18 10/20 12:17 10/20/18 12:17 Periodicals	Chinese internet giants down, not out, Barron's says » Alibaba (BABA), Tencent… Alibaba (BABA), Tencent (TCEHY) and Baidu (BIDU) have sold off sharply this year but Barron's roundtable experts - Laura Geritz, Justin Leverenz, Ruchir Sharma, and Richard Sneller - say the market is "unfairly" discounting the growth potential of these internet stocks. Reference Link BABA Alibaba $142.90 1.1 (0.78%) TCEHY Tencent $0.00 (0.00%) BIDU Baidu $191.93 0.1 (0.05%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	28 Oct 02 Nov

BLK BlackRock $401.61 1.74 (0.44%) , IVZ Invesco $22.00 0.74 (3.48%) … 12:13 10/20/18 10/20 12:13 10/20/18 12:13 Periodicals	Fund companies sued by own employees over pricey 401k plans, Barron's says » BlackRock (BLK),… BLK BlackRock $401.61 1.74 (0.44%) IVZ Invesco $22.00 0.74 (3.48%) TROW T. Rowe Price $100.13 0.31 (0.31%) SCHW Charles Schwab $46.81 0.11 (0.24%) MTB M&T Bank $162.72 2.09 (1.30%) MS Morgan Stanley $46.43 0.4 (0.87%) JPM JPMorgan $107.92 -0.21 (-0.19%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Oct 24 Oct 26 Feb
JPM JPMorgan $107.92 -0.21 (-0.19%) , BLK BlackRock $401.61 1.74 (0.44%) … 12:04 10/20/18 10/20 12:04 10/20/18 12:04 Periodicals	Khashoggi case puts financial ties to Saudis under strain, Barron's says » The suspected killing of… The suspected killing of Washington Post columnist Jamal Khashoggi is costing Saudi Arabia most of the big names that it hoped would adorn a conference known as "Davos in the Desert," with JPMorgan (JPM), BlackRock (BLK), Blackstone Group (BX) and Treasury Secretary Steven Mnuchin saying they will not attend the investment initiative, Bill Alpert writes in this week's edition of Barron's. With the crown prince now allowing the kingdom's subjects to enjoy public entertainments, big plans have been announced by the movie exhibitors AMC (AMC) and IMAX (IMAX), as well as the theme-park operator Six Flags (SIX), Barron's points out, adding that exhibitions in Saudi Arabia are already contributing to the bottom line of WWE (WWE). Reference Link JPM JPMorgan $107.92 -0.21 (-0.19%) BLK BlackRock $401.61 1.74 (0.44%) BX Blackstone $34.66 -0.61 (-1.73%) AMC AMC Entertainment $19.81 0.18 (0.92%) IMAX Imax $22.45 -0.11 (-0.49%) SIX Six Flags $66.40 -1.16 (-1.72%) WWE WWE $82.02 -1.49 (-1.78%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Oct 24 Oct 24 Oct 25 Oct 13 Nov 14 Nov 26 Feb
ABBV AbbVie $88.01 -1.93 (-2.15%) , ALXN Alexion $125.96 -0.63 (-0.50%) … 04:55 10/20/18 10/20 04:55 10/20/18 04:55 Conference/Events	The ACR and ARHP to hold annual meeting » American College of… American College of Rheumatology & Association of Rheumatology Professionals will hold the 2018 ACR/ARHP Annual Meeting in Chicago on October 19-24. ABBV AbbVie $88.01 -1.93 (-2.15%) ALXN Alexion $125.96 -0.63 (-0.50%) AMGN Amgen $201.75 -1.03 (-0.51%) AUPH Aurinia Pharmaceuticals $5.56 -0.13 (-2.28%) BMY Bristol-Myers $54.31 -1.7 (-3.04%) CELG Celgene $82.42 -0.52 (-0.63%) DGX Quest Diagnostics $102.49 0.12 (0.12%) DNA Bought by RHHBY $0.00 (0.00%) FLXN Flexion $18.96 0.33 (1.77%) GILD Gilead $73.27 -0.9 (-1.21%) GSK GlaxoSmithKline $40.87 1.25 (3.16%) REGN Regeneron $389.94 -5.45 (-1.38%) RARE Ultragenyx $63.33 -0.77 (-1.20%) QDEL Quidel $64.68 -2.85 (-4.22%) PFE Pfizer $44.50 0.48 (1.09%) NVS Novartis $87.19 0.95 (1.10%) MRK Merck $72.34 0.12 (0.17%) MCK McKesson $132.36 -0.34 (-0.26%) LLY Eli Lilly $111.91 -1.4 (-1.24%) TMO Thermo Fisher $227.13 -2.51 (-1.09%) TKPYY Takeda Pharmaceutical $0.00 (0.00%) SELB Selecta Biosciences $13.80 -1.34 (-8.85%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Oct 20 Oct 22 Oct 22 Oct 23 Oct 23 Oct 23 Oct 23 Oct 24 Oct 24 Oct 25 Oct 25 Oct 25 Oct 25 Oct 25 Oct 28 Oct 29 Oct 30 Oct 30 Oct 31 Oct 02 Nov 06 Nov 06 Nov 06 Nov 07 Nov 09 Nov 27 Nov 11 Jan 16 Feb 18 Feb 28 Apr 13 May
ABBV AbbVie $88.01 -1.93 (-2.15%) , DCPH Deciphera $22.22 -4.97 (-18.28%) … 04:55 10/20/18 10/20 04:55 10/20/18 04:55 Conference/Events	European Society for Medical Oncology (ESMO) to hold a conference » ESMO 2018 Congress to be… ESMO 2018 Congress to be held in Munich, Germany on October 19-23. ABBV AbbVie $88.01 -1.93 (-2.15%) DCPH Deciphera $22.22 -4.97 (-18.28%) TSRO Tesaro $41.81 -1.19 (-2.77%) IMGN ImmunoGen $7.44 -0.355 (-4.56%) REGN Regeneron $389.94 -5.45 (-1.38%) CRSP Crispr Therapeutics $36.02 -1.18 (-3.17%) CLVS Clovis $26.41 -3.54 (-11.82%) MRTX Mirati Therapeutics $40.04 -1.82 (-4.35%) LOXO Loxo Oncology $160.01 -7.58 (-4.52%) RHHBY Roche $0.00 (0.00%) NCNA NuCana $18.90 1.9 (11.18%) CRVS Corvus Pharmaceuticals $8.01 -0.1 (-1.23%) NTGN Neon Therapeutics $8.88 0.56 (6.73%) NKTR Nektar $48.23 -1.33 (-2.68%) EXEL Exelixis $16.27 -0.25 (-1.51%) AVEO Aveo Pharmaceuticals $2.50 -0.03 (-1.19%) KURA Kura Oncology $14.38 -1.18 (-7.58%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Oct 20 Oct 22 Oct 22 Oct 24 Oct 28 Oct 30 Oct 01 Nov 01 Nov 02 Nov 02 Nov 06 Nov 07 Nov 10 Nov 26 Nov 27 Nov 24 Dec 14 Jan 28 Apr 13 May
A Agilent $64.47 -1.28 (-1.95%) , AGLE Aeglea BioTherapeutics $9.32 -0.58 (-5.86%) … 04:55 10/20/18 10/20 04:55 10/20/18 04:55 Conference/Events	American Society of Human Genetics to hold a conference » ASHG Conference 2018 will… A Agilent $64.47 -1.28 (-1.95%) AGLE Aeglea BioTherapeutics $9.32 -0.58 (-5.86%) ALXN Alexion $125.96 -0.63 (-0.50%) RHHBY Roche $0.00 (0.00%) BMRN BioMarin $103.31 -0.52 (-0.50%) BIO Bio-Rad $280.96 -3.23 (-1.14%) MSFT Microsoft $108.55 0.01 (0.01%) ILMN Illumina $313.31 -7.98 (-2.48%) FLDM Fluidigm $7.49 -0.45 (-5.67%) HZNP Horizon Pharma $19.07 -0.01 (-0.05%) NVTA Invitae $12.86 -0.23 (-1.76%) NSTG NanoString $15.18 -0.41 (-2.63%) QGEN Qiagen $35.91 0.455 (1.28%) DGX Quest Diagnostics $102.49 0.12 (0.12%) RTRX Retrophin $25.34 0.24 (0.96%) TMO Thermo Fisher $227.13 -2.51 (-1.09%) WTKWY Wolters Kluwer $0.00 (0.00%) ARQL ArQule $4.33 -0.38 (-8.07%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Oct 21 Oct 23 Oct 23 Oct 23 Oct 24 Oct 24 Oct 24 Oct 24 Oct 24 Oct 25 Oct 25 Oct 28 Oct 30 Oct 31 Oct 01 Nov 01 Nov 01 Nov 07 Nov 07 Nov 08 Nov 13 Nov 27 Nov 28 Nov 24 Dec 18 Feb 03 Mar

CLBR Caliburn International $0.00 (0.00%) 18:27 10/19/18 10/19 18:27 10/19/18 18:27 Syndicate	Caliburn International files registration statement for proposed IPO » Caliburn International… Caliburn International announced that it has publicly filed a registration statement on Form S-1 with the SEC related to a proposed initial public offering of Class A common stock. The number of shares to be offered and the price range for the offering have not yet been determined. Caliburn has applied to list its common stock on the New York Stock Exchange under the ticker symbol "CLBR." Jefferies, Merrill Lynch, Pierce, Fenner & Smith Incorporated and SunTrust Robinson Humphrey are serving as joint book-running managers for the offering. Cowen and Company and Raymond James & Associates are acting as co-managers for the proposed offering. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SPX S&P 500 $0.00 (0.00%) , SPY SPDR S&P 500 ETF Trust $276.21 -0.12 (-0.04%) 18:10 10/19/18 10/19 18:10 10/19/18 18:10 General news	Saudi Arabia says Kashoggi killed after fight broke out in consulate, CNBC says Reference Link SPX S&P 500 $0.00 (0.00%) SPY SPDR S&P 500 ETF Trust $276.21 -0.12 (-0.04%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CE Celanese $99.62 2.61 (2.69%) 18:02 10/19/18 10/19 18:02 10/19/18 18:02 Hot Stocks	Celanese raises prices on MIBK, MIBC by EUR120/MT in Europe » Celanese announced it… Celanese announced it will increase list and off-list selling prices for Methyl Isobutyl Ketone and Methyl Isobutyl Carbinol by EUR 120 per MT. The price increases below are for orders shipped and will be effective immediately, or as contracts otherwise allow, and are incremental to any previously announced increases. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Oct
REGN Regeneron $389.94 -5.45 (-1.38%) , SNY Sanofi $44.57 0.12 (0.27%) 17:57 10/19/18 10/19 17:57 10/19/18 17:57 Hot Stocks	Regeneron, Sanofi: FDA approves asthma indication for Dupixent » Regeneron Pharmaceuticals… Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced the U.S. FDA has approved Dupixent as an add-on maintenance therapy in patients with moderate-to-severe asthma aged 12 years and older with an eosinophilic phenotype or with oral corticosteroid-dependent asthma. Dupixent inhibits the overactive signaling of interleukin-4 and interleukin-13, two key proteins that contribute to the Type 2 inflammation that may underlie moderate-to-severe asthma. This effect is associated with the reduction of inflammatory biomarkers including fractional exhaled nitric oxide, immunoglobulin E and eotaxin-3. REGN Regeneron $389.94 -5.45 (-1.38%) SNY Sanofi $44.57 0.12 (0.27%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Oct 19 Oct 20 Oct 23 Oct 28 Oct 29 Oct 06 Nov 28 Jan 22 Mar 28 Apr 13 May
XLE Energy Select Sector SPDR $71.50 -0.67 (-0.93%) , XLU Utilities SPDR $54.57 0.82 (1.53%) … 17:55 10/19/18 10/19 17:55 10/19/18 17:55 General news	Week ending ETF Scorecard: Staples, Real Estate, Utilities lead rebound » S&P500 SECTORS: … S&P500 SECTORS: Consumer Staples (XLP) up 4.4%... Real Estate (XLRE) up 3.3%... Utilities (XLU) up 3.1%... Financials (XLF) up 0.9%... Communication Services (XLC) up 0.5%... Health Care (XLV) up 0.5%... Industrials (XLI) down 1.0%... Materials (XLB) down 1.2%... Technology (XLK) down 1.2%... Consumer Discretionary (XLY) down 2.0%... Energy (XLE) down 2.0%. COMMODITY: Gold (GLD) up 0.7%... Silver (SLV) flat... Copper (JJCB) down 1.3%... Crude Oil (USO) down 2.7%... Natural Gas (UNG) up 2.9%. FIXED INCOME: High Yield (HYG) down 0.3%... Investment Grade (LQD) down 0.6%... Long-term Treasury (TLT) down 0.7%... Mid-term Treasury (IEF) down 0.2%... Short-term Treasury (SHY) flat. STRATEGY: Value (IWD) up 0.8%... Growth (IWF) down 0.7%. XLE Energy Select Sector SPDR $71.50 -0.67 (-0.93%) XLU Utilities SPDR $54.57 0.82 (1.53%) IYR DJ US Real Estate Index Fund $77.83 0.63 (0.82%) XLP Consumer Staples Sector SPDR $54.72 1.225 (2.29%) XLY Consumer Discretionary Sector SPDR $106.34 -1.06 (-0.99%) XLB S&P Select Materials SPDR $53.13 -0.36 (-0.67%) XLF Financial Select Sector $26.66 0.08 (0.30%) XLV Health Care Select Sector SPDR $91.48 -0.93 (-1.01%) XLK Technology Select Sector SPDR $70.00 -0.04 (-0.06%) XLI Industrial Select Sector SPDR $73.17 -0.31 (-0.42%) GLD SPDR Gold Trust $116.01 0.11 (0.09%) SLV iShares Silver Trust $13.74 0.05 (0.37%) USO United States Oil Fund $14.72 0.155 (1.06%) UNG United States Natural Gas Fund $26.81 0.19 (0.71%) HYG iShares iBoxx $ High Yield Corporate Bond $84.90 0.04 (0.05%) LQD iShares iBoxx $ Investment Grade Corporate Bond $112.69 -0.15 (-0.13%) TLT iShares 20+ Year Treasury Bond Fund $113.73 -0.24 (-0.21%) IEF iShares 7-10 Year Treasury Bond ETF $100.12 -0.12 (-0.12%) SHY iShares 1-3 Year Treasury Bond $82.95 -0.035 (-0.04%) IWD iShares Russell 1000 Value $122.17 0.08 (0.07%) IWF iShares Russell 1000 Growth $145.19 -0.5 (-0.34%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

INSW International Seaways $21.51 0.41 (1.94%) 17:53 10/19/18 10/19 17:53 10/19/18 17:53 Syndicate	Breaking Syndicate news story on International Seaways » International Seaways… International Seaways files $100M mixed securities shelf 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
MNR Monmouth Real Estate $15.49 0.08 (0.52%) 17:48 10/19/18 10/19 17:48 10/19/18 17:48 Hot Stocks	Monmouth Real Estate acquires industrial building in New Jersey for $85.25M » Monmouth Real Estate… Monmouth Real Estate announced the acquisition of a new 347,145 square foot industrial building located in Trenton, New Jersey at a purchase price of $85.25M. The property is net-leased for 15 years with approximately 14 years remaining. The building is situated on approximately 62 acres. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	29 Nov
TEUM Pareteum $2.47 -0.07 (-2.76%) 17:38 10/19/18 10/19 17:38 10/19/18 17:38 Syndicate	Breaking Syndicate news story on Pareteum » Pareteum files to sell… Pareteum files to sell 13.01M shares of common stock for holders 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Nov 15 Nov
TEUM Pareteum $2.47 -0.07 (-2.76%) 17:36 10/19/18 10/19 17:36 10/19/18 17:36 Syndicate	Breaking Syndicate news story on Pareteum » Pareteum files $150M… Pareteum files $150M mixed securities shelf 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Nov 15 Nov
NOC Northrop Grumman $307.77 -0.445 (-0.14%) , LMT Lockheed Martin $328.22 0.21 (0.06%) … 17:33 10/19/18 10/19 17:33 10/19/18 17:33 Periodicals	Trump to meet CEOs of Boeing, Lockheed Martin, General Dynamics, Reuters reports » President Donald Trump… President Donald Trump will meet with CEOs of Lockheed Martin (LMT), Boeing (BA), Northrop Grumman (NOC) and General Dynamics (GD) at Luke Air Force Base in Arizona, according to Reuters, citing people familiar with the matter. The group is meeting, for the second time in the past two weeks, to discuss sourcing more parts and materials in the U.S. Executives from BAE Systems (BAESY) and Honeywell (HON) will also be present at the meeting discussing supply chains. Weapons sales to Saudi Arabia were reportedly not on the agenda for the meeting, but the issue could be raised. Reference Link NOC Northrop Grumman $307.77 -0.445 (-0.14%) LMT Lockheed Martin $328.22 0.21 (0.06%) BA Boeing $356.28 -3 (-0.84%) GD General Dynamics $190.43 -0.76 (-0.40%) BAESY BAE Systems $0.00 (0.00%) HON Honeywell $153.49 -1.73 (-1.11%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Oct 23 Oct 24 Oct 24 Oct 24 Oct 30 Oct

Events

Earnings calls, analyst events, roadshows and more

ACN ...
Tomorrow at 00:00

U.S.A. Money 20/20 Conferences

The Venetian, Las Vegas, NV
Tomorrow at 00:00

2018 ACR/ARHP Annual Meeting Conferences

MCormick Place West, Chicago, IL
CLVS ...
Tomorrow at 00:00

ESMO 2018 Congress Conferences

Munich
Tomorrow at 20:30

Technology: Hardware--China Industry Meetings
CRVS ...
2018-10-22 at 00:00

ESMO 2018 Congress Conferences

Munich
BMY ...
2018-10-22 at 00:00

8th Annual IRT 2018 Conferences

Hilton Penn's Landing, Philadelphia, PA
2018-10-22 at 00:00

2018 ACR/ARHP Annual Meeting Conferences

MCormick Place West, Chicago, IL
2018-10-22 at 00:00

U.S.A. Money 20/20 Conferences

The Venetian, Las Vegas, NV
2018-10-22 at 00:00

26th Annual Symposium of Office of International Affairs Conferences

CFTC Headquarters--1155 21st Street, NW, Washington, D.C.
ACN ...
2018-10-22 at 00:00

Oracle OpenWorld Conference 2018 Conferences

San Francisco, CA

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	SIBN X SIBN SI-BONE IPO Managers: Morgan Stanley & BofA/Merrill, Canaccord, JMP Securities Priced at: $15.00 7.2M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CVU X CVU CPI Aerostructures Secondary Managers: Canaccord & B. Riley FBR Priced at: $6.25 2.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	MSC X MSC Studio City IPO Managers: Deutsche Bank, Credit Suisse & Morgan Stanley Priced at: $12.50 28.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OSMT X OSMT Osmotica Pharmaceuticals IPO Managers: Jefferies, Barclays & RBC Capital, Wells Fargo Priced at: $7.00 6.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PHAS X PHAS PhaseBio IPO Managers: Citi, Cowen & Stifel, Needham Priced at: $5.00 9.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VJET X VJET voxeljet Secondary Managers: Piper Jaffray Priced at: $2.57 4.86M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Leerink & Evercore ISI Priced at: $10.75 8.645M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	LOGC X LOGC LogicBio Therapeutics IPO Managers: Jefferies, Barclays & William Blair, Chardan Priced at: $10.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NIU X NIU Niu Technologies IPO Managers: Credit Suisse & Citi, Needham Priced at: $9.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SWI X SWI SolarWinds IPO Managers: Goldman Sachs, JPMorgan, Morgan Stanley & Credit Suisse, MLCO, Barclays, Citi, Evercore ISI, Jefferies, Macquarie, Nomura Instinet, RBC Capital, Baird, JMP Securities, KeyBanc, Mischler, Ramirez, SunTrust Priced at: $15.00 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRYS X KRYS Krystal Biotech Secondary Managers: Cowen, William Blair & Cantor Fitzgerald, Chardan, Ladenburg Priced at: $20.00 3M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AKTS X AKTS Akoustis Spot Secondary Managers: Oppenheimer Priced at: $4.25 7.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INAP X INAP Internap Spot Secondary Managers: Jefferies & Credit Suisse Priced at: $9.50 4.21M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	REPX X REPX Riley Exploration IPO Managers: SunTrust & Seaport Global, Capital One, Imperial Capital, Roth Capital $14.00-16.00 6.667M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VTEC X VTEC Valtech SE IPO Managers: JPMorgan & Morgan Stanley, Cowen, William Blair, Oddo BHF SCA $14.00-16.00 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Lexington Realty upgraded to Buy from Hold at Jefferies

TODAY'S FREE FLY STORIES

Get Full Fly Access